Urinary proteomics identifies CAD with high confidence and might also be useful for monitoring the effects of therapeutic interventions.
No takes yet. Share an insight, caveat, or question.
Delles et al. (2010) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: